[JAMA发表论文]:药物特征与生产厂家直接面向消费者的广告费用的相关性已关闭评论
Original Investigation
February 7, 2023
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising
Michael J. DiStefano, Jenny M. Markell, Caroline C. Doherty, et al
JAMA. 2023;329(5):386-392. doi:10.1001/jama.2022.23968
Key Points
Question What drug characteristics are associated with larger proportions of promotional spending allocated to direct-to-consumer advertising?
Findings&nb...
阅读全文
[Blue Journal发表论文]:家庭高流量鼻导管氧疗治疗稳定的CO2潴留COPD患者已关闭评论
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial
Kazuma Nagata, Takeo Horie, Naohiko Chohnabayashi, et al
Am J Respir Crit Care Med 2022 Dec 1;206(11):1326-1335
DOI: 10.1164/rccm.202201-0199OC
Abstract
Rationale: The long-term effects of using a high-flow nasal cannula for chronic hypercapnic respiratory failure caused by chronic obstructive pulmonary disease remain unclear. Object...
阅读全文
[JAMA Surg发表论文]:肝细胞肝癌机器人与开腹肝切除手术的安全性与疗效已关闭评论
Original Investigation
November 23, 2022
Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma
Fabrizio Di Benedetto, Paolo Magistri, Stefano Di Sandro, et al
JAMA Surg. Published online November 23, 2022. doi:10.1001/jamasurg.2022.5697
Key Points
Question Is the robotic approach a safe strategy for hepatocellular carcinoma (HCC) resection with good long-term outcomes?
Findings In thi...
阅读全文
[Lancet Respir Med发表论文]:辉瑞mRNA疫苗对新冠病毒奥密克戎变异株BA.1和BA.2感染导致的住院和急诊就诊的影响已关闭评论
ARTICLES|ONLINE FIRST
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
Sara Y Tartof, Jeff M Slezak, Laura Puzniak, et al
Lancet Respir Med Published:October 07, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00354-X
Summary
Background
The SARS-CoV-2 omicron (B.1.1.529 BA.1) ...
阅读全文
[Lancet Respir Med发表论文]:接受VV-ECMO治疗患者的输血实践已关闭评论
ARTICLES|ONLINE FIRST
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study
Gennaro Martucci, Matthieu Schmidt, Cara Agerstrand, et al.
Lancet Respir Med Published:October 11, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00353-8
Summary
Background
In patients receiving venovenous (VV) extracorporeal membrane oxygenation (ECMO) packed red blood cell (PRBC) transfusion thresholds are usually hig...
阅读全文
[Lancet Respir Med发表论文]:接受VV-ECMO治疗的新冠肺炎患者死亡相关的预后因素已关闭评论
ARTICLES|ONLINE FIRST
Prognostic factors associated with mortality among patients receiving venovenous extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis
Alexandre Tran, Shannon M Fernando, Bram Rochwerg, et al.
Lancet Respir Med Published: October 10, 2022
DOI: https://doi.org/10.1016/S2213-2600(22)00296-X
Summary
Background
Venovenous extracorporeal membrane oxygenation (ECMO) can be considered for patients with ...
阅读全文
[Lancet Respir Med发表论文]:欧洲健康足月婴儿的呼吸道合胞病毒疾病负担已关闭评论
ARTICLES|ONLINE FIRST
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
Joanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
Lancet Respir Med Published:November 10, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00414-3
Summary
Background
Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants. The burden of RSV infection in healthy term infants ha...
阅读全文
[Lancet Respir Med发表论文]:接受ECMO治疗的新冠肺炎患者住院及6个月预后已关闭评论
ARTICLES|ONLINE FIRST
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
Roberto Lorusso, Maria Elena De Piero, Silvia Mariani, et al.
Lancet Respir Med Published:November 16, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00403-9
Summary
Background
Extracorporeal membrane oxygenation (ECMO) has been widely used in patients with ...
阅读全文
[Lancet Respir Med发表论文]:法匹拉韦治疗新冠肺炎住院患者已关闭评论
ARTICLES|ONLINE FIRST
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
Pallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
Lancet Respir Med Published:December 14, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00412-X
Summary
Background
COVID-19 has overwhelmed health services globally. Oral antiviral therapies are ...
阅读全文
[Lancet Respir Med发表论文]:新冠病毒变异株流行期间有经验的欧洲中心新冠肺炎患者ECMO治疗的预后比较已关闭评论
ARTICLES|ONLINE FIRST
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study
Matthieu Schmidt, David Hajage, Micha Landoll, et al.
Lancet Respir Med Published:January 11, 2023
DOI:https://doi.org/10.1016/S2213-2600(22)00438-6
Summary
Background
To inform future research and ...
阅读全文